首页> 外国专利> 2-(3-PHENYL-2-PIPERAZINYL-3,4-DIHYDROQUINAZOLINE-4-YL) ACETIC ACIDS AS ANTI-VIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALO VIRUSES

2-(3-PHENYL-2-PIPERAZINYL-3,4-DIHYDROQUINAZOLINE-4-YL) ACETIC ACIDS AS ANTI-VIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALO VIRUSES

机译:2-(3-苯甲基-2-哌嗪基-3,4-二氢喹唑啉-4-基)乙酸作为抗病毒剂,尤其是对细胞毒的抗药性

摘要

2-(2-(4-Phenyl-1-piperazinyl)-3-phenyl-3,4-dihydro-4-quinazolinyl)-acetic acid derivatives (I) are new. 2-(2-(4-Phenyl-1-piperazinyl)-3-phenyl-3,4-dihydro-4-quinazolinyl)-acetic acid derivatives of formula (I) and their salts, solvates and hydrated salts are new. [Image] Ar : aryl (optionally substituted (os) by 1-3 Q); Q : alkyl, alkoxy, CHO, COOH, alkylcarbonyl, alkoxycarbonyl, CF 3, halo, CN, OH, NH 2, alkylamino, CONH 2 or NO 2 (where alkyl is os by 1-3 halo, NH 2, alkylamino, OH or aryl), or Q + Q : a group completing a fused 1,3-dioxolan, cyclopentane or cyclohexane ring; R 1-R 3H, alkyl, alkoxy, CN, halo, NO 2 or CF 3, or two of R 1-R 3a group completing a fused 1,3-dioxolan, cyclopentane or cyclohexane ring, and R 4, R 5H or alkyl, or R 4 and R 5 on opposite C atoms : CH 2, CHMe or CMe 2 bridge. provided that R 1-R 3 are not all H. An independent claim is included for the preparation of (I). ACTIVITY : Virucide. In tests for effectiveness against human cytomegalovirus (HCMV) infections in human foreskin fibroblast cultures, 2-(2-(4-(4-fluoro-3-methylphenyl)-1-piperazinyl)-3-(3-trifluoromethyl)-phenyl)-3,4-dihydro-4-quinazolinyl)-acetic acid (Ia) had an antiviral EC 50 value of 0.027 mu M and a cytotoxic CC 5 0 value of 17 mu M (corresponding to a selectivity index of 630). MECHANISM OF ACTION : None given.
机译:2-(2-(2-(4-苯基-1-哌嗪基)-3-苯基-3,4-二氢-4-喹唑啉基)-乙酸衍生物(I)是新的。式(I)的2-(2-(2-(4-苯基-1-哌嗪基)-3-苯基-3,4-二氢-4-喹唑啉基)-乙酸衍生物及其盐,溶剂化物和水合盐是新的。 [图像] Ar:芳基(可被1-3 Q取代(os)); Q:烷基,烷氧基,CHO,COOH,烷基羰基,烷氧基羰基,CF 3,卤素,CN,OH,NH 2,烷基氨基,CONH 2或NO 2(其中烷基为1-3个卤素的os,NH 2,烷基氨基,OH或芳基),或Q + Q:完成稠合的1,3-二氧戊环,环戊烷或环己烷环的基团; R 1> -R 3> H,烷基,烷氧基,CN,卤素,NO 2或CF 3,或R 1> -R 3>中的两个>完成稠合的1,3-二氧戊环,环戊烷或环己烷环的基团,和在相对的C原子上的R 4>,R 5> H或烷基,或R 4>和R 5>:CH 2,CHMe或CMe 2桥。前提是R 1> -R 3>不都是H。(I)的制备包括一个独立的权利要求。活动:杀病毒剂。在人包皮成纤维细胞培养物中针对人巨细胞病毒(HCMV)感染的有效性测试中,2-(2-(4-(4-(4-氟-3-甲基苯基)-1-哌嗪基)-3-(3-三氟甲基)-苯基) -3,4-二氢-4-喹唑啉基)-乙酸(Ia)的抗病毒EC 50值为0.027μM,细胞毒性CC 5 0值为17μM(对应于630的选择性指数)。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号